Invaio Sciences Overview
- Founded
-
2018
- Status
-
Private
- Employees
-
120
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$50M
- Investors
-
5
Invaio Sciences General Information
Description
Operator of multi-platform technology company intended to solve pressing agriculture, nutrition, and environmental challenges. The company's platform leverages advanced sciences to understand the physiology of insects, and the diverse systems of nature, enabling clients to give a unique angle at reducing the use of pesticides globally and develop technology that's mindful of beneficial, bad for pests, and safer for all.
Contact Information
Website
www.invaio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Agriculture
Other Industries
Biotechnology
Environmental Services (B2B)
Primary Office
- 75 Moulton Street
- Cambridge, MA 02138-1127
- United States
+1 (617) 000-0000
Invaio Sciences Timeline
Invaio Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Debt - General | 13-Oct-2021 | $50M | 00000 | Completed | Generating Revenue | |
| 3. Later Stage VC (Series C) | 25-May-2021 | 000.00 | 00000 | Completed | Generating Revenue | |
| 2. Early Stage VC (Series B) | 05-Feb-2020 | $40M | $62M | 00000 | Completed | Startup |
| 1. Early Stage VC (Series A) | 01-Jan-2018 | $22M | $22M | 0000 | Completed | Startup |
Invaio Sciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00.0 | 00.0 | 00 | 00.0 | 00.000 | |
| Series A-1 | 0,000,000 | 00.000000 | 00.0 | 00.0 | 00 | 00.0 | 00.000 | |
| Series A | 11,298,177 | $0.001000 | $1 | $1 | 1x | $1 | 20.4% |
Invaio Sciences Executive Team (8)
Invaio Sciences Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Ena Cratsenburg | Self | Board Member | 000 0000 |
| Gerardo Ramos Ph.D | Invaio Sciences | Chief Science Officer & Board Member | 000 0000 |
| Hugh Grant | Self | Board Member | 000 0000 |
| Iya Khalil Ph.D | Self | Board Member | 000 0000 |
| Pietro Tataranni MD | Self | Board Member | 000 0000 |
Invaio Sciences Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Invaio Sciences Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Alexandria Venture Investments | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Bluwave Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Investbridge Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Stage 1 Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Flagship Pioneering | Venture Capital | Minority | 000 0000 | 000000 0 |